相关实验视频

Updated: Jul 3, 2025

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

17.9K

洛拉提尼布在阿莱克提尼布诱导的肺炎后:一个病例报告

James A Fletcher1,2, William J Mullally1, Rahul Ladwa1,2

  • 1Division of Cancer Services, Princess Alexandra Hospital, Brisbane, Queensland, Australia.

JTO clinical and research reports
|February 15, 2024
PubMed
概括

无细胞淋巴瘤激酶 (ALK) 氨酸激酶抑制剂可以导致间歇性肺病 (ILD). 本案例研究详细介绍了ALK重组NSCLC患者的洛拉提尼布顺序成功测序,该患者先前患有alectinib诱导的ILD.

关键词:
阿莱克提尼布 (Alectinib) 是一种药物.案例报告案例报告洛拉提尼布 (Lorlatinib) 是一种药物.在NSCLCLC中,我们可以看到.肺炎是一种肺炎.

更多相关视频

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-308:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

1.1K

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
166